Evidence map›Paper›PMID 41488011›Full record

ReviewClinical ophthalmology (Auckland, N.Z.)2025

Understanding Keratoconus in Down Syndrome: From Etiology to Management - A Narrative Review.

Venugopal Anitha, Nambi Nallasamy, Josephine S Christy, Olav Kristianslund, Kirk A J Stephenson, Hassan Hashemi, Revathi Rajaraman, Soheila Asgari

Abstract readReview
In one paragraph

Review in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Venugopal AnithaDepartment of Cornea & Refractive Services, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Tirunelveli, TN, India.
Nambi NallasamyDepartment of Ophthalmology and Visual Sciences, Kellogg Eye Centre, Ann Arbor, MI, USA.
Josephine S ChristyDepartment of Cornea & Refractive Services, Aravind Eye Hospital, Pondicherry, India.
Olav KristianslundDepartment of Ophthalmology, Oslo University Hospital, Oslo, Norway.ORCID 0000-0003-3390-9811
Kirk A J StephensonDepartment of Ophthalmology, Royal Victoria Eye & Ear Hospital, Dublin, Ireland.ORCID 0000-0002-7462-7725
Hassan HashemiDepartment of Ophthalmology, Noor Research Centre for Ophthalmic Epidemiology, Noor Eye Hospital, Tehran, Iran.ORCID 0000-0002-6086-1537
Revathi RajaramanDepartment of Cornea & Refractive services, Aravind Eye Hospital, Coimbatore, TN, India.
Soheila AsgariDepartment of Ophthalmology, Noor Ophthalmology Research Centre, Noor Eye Hospital, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paediatricians are often the first to identify children with DS and their awareness on associated ocular comorbidities, play a critical role in ensuring timely referral to general ophthalmologists for diagnosis and management. Among these, keratoconus (KC) has a significantly higher prevalence among Down syndrome (DS) compared to the general population. The awareness and understanding of KC, is essential for preventing vision loss. This review summarizes the current understanding of KC in DS, on epidemiology, pathophysiology, diagnostic challenges, and management. The children with DS, have thinner and steeper corneas since birth, complicates the diagnostic and management protocols. Poor cooperation of the children for imaging, compromised scan qualities, need for sedation and repeatability of scans poses diagnostic challenges. Early intervention with corneal cross-linking (CXL) is shown to be effective in halting disease progression. The surgical options in advanced cases, carry higher risks in DS patients due to factors such as eye rubbing, increased infection rates, and challenges in postoperative compliance. Managing KC in DS requires a comprehensive approach involving early referral by Paediatricians, pre-emptive diagnosis, and timely intervention with CXL to prevent disease progression. Future research should focus on preclinical gene prediction and developing standardized screening protocols for KC among DS to prevent vision loss and thereby improve quality of life among them.

Indexed as

acute hydropscorneal tomographydown syndromekeratoconus

Identifiers

PMID41488011
PMCPMC12764348

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.